https://health-union.com/wp-content/uploads/2026/02/HU-site-FEB26-2026-pharma-marketing-pulse-report-feature.png
560
1468
Meghan McNally
https://health-union.com/wp-content/uploads/2026/06/healthunion-header-logo.png
Meghan McNally2026-02-20 13:00:022026-02-22 20:17:54Health Union and solli Unveil 2026 Pharma Marketing Pulse Report, Signaling a New Era of Accountability and Deep Patient EngagementPeruse Health Union’s latest news announcements on survey findings, awards, leadership, and more. News media interested in learning more about how Health Union can help them tell the health stories they want to tell can visit our Press Kit and Resource Center for News Media.
https://health-union.com/wp-content/uploads/2026/02/HU-site-FEB26-2026-pharma-marketing-pulse-report-feature.png
560
1468
Meghan McNally
https://health-union.com/wp-content/uploads/2026/06/healthunion-header-logo.png
Meghan McNally2026-02-20 13:00:022026-02-22 20:17:54Health Union and solli Unveil 2026 Pharma Marketing Pulse Report, Signaling a New Era of Accountability and Deep Patient Engagement
CGRP Therapies for Migraine Effect on Quality of Life
Survey finds positive HCP relationships, negative quality of life for chronic migraine patients who currently use vs. never used CGRP therapies.

CFTR Modulator Use Among Cystic Fibrosis Patients
A Cystic Fibrosis survey finds patients who have never used a CFTR modulator are more likely to say CF negatively impacts their overall quality of life.

Health Union Ranks No. 209 on 2019 Deloitte 500™
Health Union has ranked among Deloitte Technology Fast 500 ™ for the second consecutive year due to exponential growth since the company started in 2010.

Survey of Adults with Atopic Dermatitis Symptoms As Kids
84% of survey respondents who experienced atopic dermatitis symptoms as kids said they were diagnosed more than 10 years ago.
Health Union and the Institute for Responsible Influence Set the New Gold Standard for Patient Advocacy and Digital Compliance
Health Union and the Institute for Responsible Influence set the new gold standard for patient advocacy and digital compliance.
Contact
1218 Chestnut St., 3rd Floor
Philadelphia, PA 19107
Phone: 484-985-9715
Fax: 484-450-2513
![]()
Privacy Notice
Terms of Use
Consumer Health Notice
Your Privacy Choices ![]()
Privacy Rights Request Form
Join Our Team
Press Kit




